+ Filter
Loading...
Custom Services order now ship next day

CA9

Anti-CA9 Recombinant Antibody Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs offers innovative anti-CA9 products that target the highly selective carbonic anhydrase IX (CA9) enzyme, leveraging its unique expression profile in tumor tissues. Our anti-CA9 products are subjected to comprehensive testing and validation processes to guarantee their superior quality and dependability. This commitment to excellence empowers researchers to conduct critical studies with confidence.

CA9: An Appealing Target for Cancer Treatment

CA9, or Carbonic Anhydrase IX, is primarily located in the gastrointestinal system, where it plays an essential role in the regulation of acid production. This transmembrane glycoprotein features an active site located extracellularly and is classified as a tumor-associated isoenzyme of carbonic anhydrase. Research has shown that CA9 is significantly over-expressed in clear cell renal cell carcinoma (ccRCC) associated with VHL mutations, as well as in various hypoxic solid tumors. Due to its minimal presence in normal tissues combined with its heightened expression in numerous cancer types, CA9 has emerged as an attractive target for therapeutic interventions.

Alternative Names

Carbonic anhydrase 9; Carbonic anhydrase IX; CAIX; MN

Background

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidneys or most other normal tissues. It may be involved in cell proliferation and transformation.

Anti-CA9 rAb Products

Creative Biolabs presents an extensive range of recombinant antibodies targeting CA9, engineered for optimal efficacy in research applications. These antibodies are crafted for high specificity and binding affinity, enabling reliable inhibition of CA9 activity. Moreover, we offer diverse antibody formats to meet various immunological investigations, empowering researchers to advance projects with efficacy and accuracy.

Table 1. Featured anti-CA9 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
HPAB-0784-CN Human Anti-CA9 Recombinant Antibody (clone G37) Human Human IgG FC, ELISA, Inhib, FuncS, Cyt, BI, IHC
TAB-1458CL Anti-Human CA9 Recombinant Antibody (MSC3) Human, Mouse Human IgG1 FC
PABZ-017 Mouse Anti-CA9 Recombinant Antibody (clone M75) Human Mouse IgG2b WB, FuncS
TAB-707 Anti-CAIX/CA9 Recombinant Antibody (Girentuximab) Human Mouse IgG1 - kappa WB, FuncS, IF, Neut, ELISA, FC, IP, PK, IHC, Activ
HPAB-0104-LSX Human Anti-CA9 Recombinant Antibody Human Human IgG ELISA, FC, Inhib

Creative Quality Control

Creative Biolabs is committed to delivering top-tier anti-CA9 recombinant antibodies, tailored for breakthroughs in immunological research. Our state-of-the-art laboratories employ rigorous quality control measures to ensure that each antibody exhibits outstanding specificity and efficacy. Furthermore, with a focus on continuous improvement, our expert team diligently enhances our production techniques, ensuring that our offerings remain at the forefront of biotechnological advancements.

Fig.1 WB analysis. (Creative Biolabs Original)Fig.1 WB analysis of anti-CA9 antibody
(Cat# PABZ-017, Creative Biolabs).

Fig.2 ELISA analysis. (Creative Biolabs Original)Fig.2 ELISA analysis of anti-CA9 antibody
(Cat# PABZ-017, Creative Biolabs).

Fig.3 Dot Blot analysis. (Creative Biolabs Original)Fig.3 Dot Blot analysis of anti-CA9 antibody.
(Cat# PABZ-017, Creative Biolabs).

Fig.4 Dot Blot analysis. (Creative Biolabs Original)Fig.4 Dot Blot analysis of anti-CA9 antibody.
(Cat# TAB-707, Creative Biolabs).

Fig.5 SEC-HPLC analysis. (Creative Biolabs Original)Fig.5 SEC-HPLC analysis of anti-CA9 antibody
(Cat# TAB-1458CL, Creative Biolabs).

Fig.6 ELISA analysis. (Creative Biolabs Original)Fig.6 ELISA analysis of anti-CA9 antibody
(Cat# TAB-1458CL, Creative Biolabs).

Customer Reviews

Excellent
Do***e
Mouse Anti-CA9 Recombinant Antibody (clone 3E4) (MOB-0310CT)
I am highly impressed with the mouse anti-CA9 recombinant antibody from Creative Biolabs. The antibody exhibited excellent specificity and affinity, allowing for clear and distinct localization of CA9 in the sample. The fluorescence signals were bright and consistent, making it easy to visualize the target protein. The use of this antibody has further promoted the success of my project.
22/Jun/2022
Excellent
Da***l
Rabbit Anti-CA9 Recombinant Antibody (clone CBACN-083) (MRO-0229-CN)
The Rabbit Anti-CA9 Recombinant Antibody proved to be a game-changer for my IHC experiments. Its exceptional specificity and sensitivity delivered clear, strong staining, making CA9 expression easy to visualize. With minimal background noise, I was able to obtain precise results that have significantly advanced my tumor biology research.
2/Dec/2022
Excellent
Bo***b
Mouse Anti-CA9 Recombinant Antibody (clone AB-MN-21.5.2) (HPAB-1174WJ)
The Anti-CA9 Recombinant Antibody from Creative Biolabs proved to be a valuable asset in my ADCC assays. Its strong binding to CA9 and potent cytotoxic activity against target cells made it a reliable and effective tool for my research. The consistent and reproducible results I obtained solidified my confidence in this product.
13/May/2024

rAb Production

Our proprietary anti-CA9 recombinant antibody platform utilizes genetically engineered cells to produce high-quality, CA9-specific antibodies. This advanced system enables scalable and efficient manufacturing, ensuring a reliable supply for diverse uses.

Featured Anti-CA9 Recombinant Antibody Production PlatformsFig.7 Milligram-scale. (Creative Biolabs Original)
Fig.7 Milligram-scale anti-CA9 recombinant antibody production.

Fig.8 Gram-scale. (Creative Biolabs Original)Fig.8 Gram-scale anti-CA9 recombinant antibody production.

rAb Modalities

Creative Biolabs delivers a wide range of high-quality anti-CA9 recombinant antibodies available in various formats to suit your specific research needs.

Fig.9 CA9 antibody production and modalities. (Creative Biolabs Original)Fig.9 Full-length anti-CA9 recombinant antibody production and modalities.

CA9-Targeted Drug Information

Table 2. Public drug targeting CA9.

Highest Phase Mechanism of Action Product Category Condition Organization
Pre-Registered Anti-CA9 (Carbonic Anhydrase IX) Chimeric Monoclonal Antibodies
Nuclear Imaging Agents
Radioimmunoconjugates
Radiopharmaceuticals
Zirconium Complexes
Cancer
Cancer, bladder (urothelial carcinoma)
Cancer, kidney (renal cell carcinoma, clear cell)
Cancer, solid tumor
Triple negative breast cancer
Heidelberg Pharma (Originator)
Memorial Sloan-Kettering Cancer Center
Radboud Universiteit Nijmegen
Telix Pharmaceuticals
Wilex (Heidelberg Pharma)
Phase I Anti-CA9 (Carbonic Anhydrase IX) Cancer Immunotherapy
Chimeric Monoclonal Antibodies
Radioimmunoconjugates
Radionuclide Therapy
Radiopharmaceuticals
Yttrium Complexes
Cancer, kidney
Cancer, kidney, metastatic
Ludwig Institute for Cancer Research
Memorial Sloan-Kettering Cancer Center
Radboud Universiteit Nijmegen
Preclinical Anti-CA9 (Carbonic Anhydrase IX) Cancer Immunotherapy
Chimeric Monoclonal Antibodies
Nuclear Imaging Agents
Radioimmunoconjugates
Radiopharmaceuticals
Zirconium Complexes
Cancer, colorectal Provincial Health Services Authority (Originator)
Preclinical Anti-CA9 (Carbonic Anhydrase IX)
Anti-CD3 (T-Cell Surface Glycoprotein CD3)
Signal Transduction Modulators
T-Cell Engagers
Adoptive Cell Therapy
Bispecific Antibody Fusions
Cancer Immunotherapy
Single-Chain V-Domain Antibody Fragment (scFv)
Single-Domain Antibodies
Cancer Biotheus (Originator)
Preclinical Antimitotic Drugs
Carbonic Anhydrase Type IX Inhibitors
Microtubule Destabilizers (Tubulin Polymerization Inhibitors)
Auristatins
Peptide-Drug Conjugates
Polypeptides, from 10 AA to 40 AA
Site-Specific Drug Delivery
Cancer ETH Zuerich (Originator)
Philochem
Preclinical Anti-CA9 (Carbonic Anhydrase IX) Cancer Immunotherapy
Chimeric Monoclonal Antibodies
Cancer, kidney (renal cell carcinoma) Kyowa Kirin (Originator)
Preclinical Carbonic Anhydrase Type IX Inhibitors Indium Complexes
Nuclear Imaging Agents
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radiopharmaceuticals
Cancer Johns Hopkins University School Medicine (Originator)
Preclinical Anti-CA9 (Carbonic Anhydrase IX) Antibodies
Cancer Immunotherapy
Cancer Checkpoint Therapeutics
Dana-Farber Cancer Institute (Originator)
Preclinical Fusion Proteins
Polypeptides, from 41 AA
Cancer
Cancer, kidney
Dendreon Pharmaceuticals (Originator)
Biological Testing Anti-CA9 (Carbonic Anhydrase IX) Cancer Immunotherapy
Murine Monoclonal Antibodies
Cancer, kidney Guangzhou Tongqi Technology (Originator)

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

If you're in search of a trustworthy and high-performance anti-CA9 antibody, look no further. Reach out to us today to tailor a solution that meets your unique requirements.

  • 0
  • 0
Cart
    Go to compare

    Go to compare